摘要
目的:观察“三叉神经痛可停”治疗原发性三叉神经痛的疗效。方法:采用随机双盲法进行研究,将40例患者随机分为治疗组和对照组各20例,治疗组予以“三叉神经痛可停”口服,对照组予以苯妥英钠口服,疗程21d。结果:治疗组总有效率90．0％,对照组总有效率50．0％,差异有显著性意义(P<0．025)。结论:“三叉神经痛可停”对原发性三叉神经痛有较好疗效。
Objective: To investigate the curative effect of Shanchashenjing Tongketing on primary trigeminal neuralgia. Methods: 40 patients were divided randomly into therapeutic group and control group, Sanchashenjing Tongketing was taked orally in therapeutic group and difetoin orally in control group for 21 days. Results: The total effective rate was 90.0% in the therapeutic group and 50.0% in the control group, which showed that the difference was significant (P<0.025). Conclusion: the Sanchashenjing Tongketing has a good effect for primary trigeminal neuralgia.
出处
《世界中西医结合杂志》
2006年第1期49-50,共2页
World Journal of Integrated Traditional and Western Medicine
基金
国家重点科技攻关项目
NO:96-901-5-29
河南省科技攻关重大项目
NO:971200600
关键词
三叉神经痛
原发性
三叉神经痛可停
临床研究
Trigeminal neuralgia
primary
Sanchashenjing Tongketing
clinical research
